Samy Hadjadj

26PUBLICATIONS
167CO-AUTHORS
Nutrigenomics and personalised nutritionBehavioural epidemiologyEpidemiological modellingEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 15, 2025
Expert perspectives on incorporating glucagon-like peptide-1 receptor agonist in diabetes and chronic kidney disease: challenges and opportunities.

Jean-Michel Halimi, Laurent Fauchier, Alexandre Karras

|Feb 04, 2025
Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population.

Marion Camoin, Kamel Mohammedi, Pierre-Jean Saulnier

|Aug 22, 2024
Diabetes Overtreatment and Hypoglycemia in Older Patients With Type 2 Diabetes on Insulin Therapy: Insights From the HYPOAGE Cohort Study.

Antoine Christiaens, Anne-Sophie Boureau, Béatrice Guyomarch

|May 23, 2024
Heterogeneity of glycaemic phenotypes in type 1 diabetes.

Guy Fagherazzi, Gloria A Aguayo, Lu Zhang

|May 15, 2024
A prospective observational study to evaluate a possible relationship between vitamin K antagonist therapy and risk of peripheral arterial disease in patients with type 2 diabetes.

Olivier Bourron, Kamel Mohammedi, Joe De Keizer

|Mar 18, 2024
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial.

Stefan R Bornstein, Dick de Zeeuw, Hiddo J L Heerspink

Pageof 5

Frequent Collaborators

10 joint publications

Ronan Roussel

9 joint publications

Louis Potier

9 joint publications

Pierre-Jean Saulnier

8 joint publications

Pierre Gourdy